Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies

Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies

Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease whose incidence has risen worldwide in recent years. Accumulating evidence shows that oxidative stress plays an essential role in the pathogenesis and progression of IBD. This review highlights the generation of reactive oxygen s...

Full description

Bibliographic Details
Main Authors:	Tian Tian, Ziling Wang, Jinhua Zhang
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	Oxidative Medicine and Cellular Longevity
Online Access:	http://dx.doi.org/10.1155/2017/4535194

Similar Items

Antioxidant Therapy in Inflammatory Bowel Diseases
by: Katarzyna Dziąbowska-Grabias, et al.
Published: (2021-03-01)

The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models
by: Ioana Miruna Balmus, et al.
Published: (2016-01-01)

Novel pathomechanisms in inflammatory neuropathies
by: David Schafflick, et al.
Published: (2017-11-01)

Oxidative and Antioxidative Stress Status in Children with Inflammatory Bowel Disease as a Result of a Chronic Inflammatory Process
by: Urszula Grzybowska-Chlebowczyk, et al.
Published: (2018-01-01)

Is oxidative stress associated with activation and pathogenesis of inflammatory bowel disease?
by: Yuksel Mahmut, et al.
Published: (2017-01-01)

Oxidative stress and DNA damage - contributions to Inflammatory Bowel Disease
by: Cristiana Maria Matos da Costa Pereira
Published: (2019)

Oxidative Stress Markers in Inflammatory Bowel Diseases: Systematic Review
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2020-08-01)

Nitric oxide as a potential biomarker in inflammatory bowel disease
by: Nesina Avdagić, et al.
Published: (2013-02-01)

Therapy in inflammatory bowel disease
by: Gustavsson, Anders
Published: (2012)

Implications of Antioxidant Systems in Inflammatory Bowel Disease
by: Guiping Guan, et al.
Published: (2018-01-01)

Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson’s Disease Targeting Neuroinflammation
by: Chiung-Mei Chen, et al.
Published: (2021-01-01)

The Bidirectional Interactions between Resveratrol and Gut Microbiota: An Insight into Oxidative Stress and Inflammatory Bowel Disease Therapy
by: Yaolian Hu, et al.
Published: (2019-01-01)

Redox signaling and Alzheimer’s disease: from pathomechanism insights to biomarker discovery and therapy strategy
by: Yuan-Yuan Chen, et al.
Published: (2020-09-01)

Modern therapy for inflammatory bowel disease
by: Novaković Aleksandra
Published: (2017-01-01)

Iron Therapy in Inflammatory Bowel Disease
by: Aditi Kumar, et al.
Published: (2020-11-01)

Trends in Inflammatory Bowel Disease Therapy
by: L Sutherland, et al.
Published: (1990-01-01)

Trends in Inflammatory Bowel Disease Therapy
by: F Martin, et al.
Published: (1993-01-01)

Prostaglandins in Inflammatory Bowel Disease Therapy
by: Lonnie R Empey, et al.
Published: (1993-01-01)

Immunoglobulin Therapy in Inflammatory Bowel Disease
by: Douglas S Levine
Published: (1993-01-01)

Biosimilar therapy for inflammatory bowel disease
by: Cristina Avendaño-Solá, et al.

Inflammatory Bowel Diseases: Focus on Therapy
by: Cristina Tocia, et al.
Published: (2018-02-01)

Biological Therapy for Inflammatory Bowel Disease
Published: (2020)

The antioxidant vitamin status of inflammatory bowel disease patients
by: Kaganson, Nicola
Published: (2014)

MSC therapy for inflammatory bowel disease
by: Mikhail A. Konoplyannikov, et al.
Published: (2021-03-01)

Metallothioneins in Inflammatory Bowel Diseases: Importance in Pathogenesis and Potential Therapy Target
by: Anna Socha-Banasiak, et al.
Published: (2021-01-01)

Potential Modulatory Microbiome Therapies for Prevention or Treatment of Inflammatory Bowel Diseases
by: Daan V. Bunt, et al.
Published: (2021-05-01)

Infectious causes of acute ischemic stroke: pathomechanisms and distribution of brain infarct
by: Wenyu Li, et al.
Published: (2020-09-01)

Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients
by: Dorra Bouzid, et al.
Published: (2013-01-01)

Radicular and pseudoradicular pain symptoms - pathomechanisms of injury, diagnostics and therapy
by: Wioletta Jagucka-Mętel, et al.
Published: (2019-04-01)

Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease.
by: Cristiana Costa Pereira, et al.
Published: (2017-01-01)

Inflammatory mechanisms and oxidative stress in prostatitis: the possible role of antioxidant therapy
by: Paulis G
Published: (2018-09-01)

Stem cells therapy in inflammatory bowel disease
by: Venera Rakhmetova, et al.
Published: (2017-12-01)

Update of Immunomodulatory Therapy for Inflammatory Bowel Disease
by: Charles N Bernstein
Published: (1994-01-01)

Biologic therapies for chronic inflammatory bowel disease
by: M. P. Martínez-Montiel, et al.

Immunomodulatory therapy in paediatric inflammatory bowel disease
by: András Arató
Published: (2013-10-01)

Immunosuppressive and Immunomodulatory Therapy for Inflammatory Bowel Disease
by: Charles N Bernstein, et al.
Published: (1993-01-01)

ABC of topical therapy in inflammatory bowel disease
by: Thomas M Goodsall, et al.
Published: (2020-08-01)

Novel and Emerging Therapies for Inflammatory Bowel Disease
by: Badr Al-Bawardy, et al.
Published: (2021-04-01)

Adherence to therapy of patients with inflammatory bowel diseases
by: A I Parfenov, et al.
Published: (2018-12-01)

Topical nicotine therapy for inflammatory bowel disease
by: Ingram, John Robert
Published: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ublv8em17jrtb0tcdc0m362ua9